Morgan Lewis & Bockius represented CodaMetrix in the transaction. CodaMetrix, an artificial intelligence (AI) solution provider announced closing of its $40 million Series B funding round. Transformation...
Codametrix’s $40 Million Series B Financing Round
Tisch Family’s Investment in Gotham FC
Morgan Lewis represented Next 3 and Carolyn Tisch Blodgett in the transaction. Next 3 and Carolyn Tisch Blodgett, founder and CEO of Next 3, on behalf...
Vendasta Technologies Inc.’s Acquistion of Broadly
Osler Hoskin & Harcourt LLP acted as Canadian counsel for Vendasta Technologies. TD Securities (USA) LLC served as financial advisor to Broadly, and Morgan, Lewis &...
Replimune Group’s $260 Million Common Stock Offering
Morgan Lewis advised Replimune Group on the deal. Replimune Group Inc. announced its approximately $260 million public offering of 6,810,658 shares of common stock, inclusive of...
Strand Therapeutics’ $97 Million Series A Financing Round
Morgan Lewis & Bockius advised Strand Therapeutics in the transaction. Strand Therapeutics secured additional capital for its Series A financing round, which now totals $97 million. FPV...
Vendasta’s Acquisition of Yesware
Morgan, Lewis & Bockius advised Yesware, while Osler, Hoskins, Harcourt advised Vendasta on the deal. Vendasta announced the acquisition of Yesware, a private Boston-based company that offers...
Premier Orthopaedics’ Partnership Agreement with Healthcare Outcomes Performance Co.
Morgan Lewis represented Premier Orthopaedics in the transaction. Premier Orthopaedics announced its partnership agreement with Healthcare Outcomes Performance Co. (HOPCo). Premier Orthopaedics, with more than 35...
Selina Hospitality’s $147.5 Million Notes Offering
Morgan, Lewis & Bockius represented Selina Hospitality PLC on the issuance. Selina Hospitality PLC announced its issuance of $147.5 million aggregate principal amount of 6% senior...
Reify Health’s $220 Million Series D Funding Round
Morgan Lewis represented Reify Health in the transaction. Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220 million Series D...
Oak Hill Bio’s Development of Rare Autoimmune Diseases Pipeline
Morgan Lewis represented Takeda Pharmaceutical Company Limited in its transaction with clinical-stage rare disease therapeutics company Oak Hill Bio. Oak Hill Bio plans to advance a...
Selina’s Merger with BOA Acquisition Corp.
Morgan, Lewis & Bockius advised Selina, while King & Spalding advised BOA on the transaction. Selina, the fast-growing hospitality and experiential brand targeting Millennial and Gen...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...